Bocharov V E, Varnakov S I, Makarov I A, Mel'nikova M V
Vestn Oftalmol. 1999 Jan-Feb;115(1):22-4.
Potentialities of lymphotropic method of drug administration for arresting inflammation after intraocular cataract correction were studied in 60 patients aged 48-63 years. Extracapsular cataract extraction with implantation of posterior-chamber Alexeev's intraocular lens (IOL) was carried out in all of them. Patients with complications of surgery and a history of inflammations in the operated eye were not included in the study. For assessing lymphotherapy effect on drug concentration in the blood, bloodflow aggregation gradient in the bulbar conjunctiva venules was estimated in the operated on eye. The data indicate that lymphotherapy is an effective method for treating early postoperative inflammations after IOL implantation, shortening the treatment terms in comparison with traditional therapy.
对60名年龄在48至63岁之间的患者研究了用于抑制白内障人工晶状体植入术后炎症的亲淋巴给药方法的潜力。所有患者均进行了囊外白内障摘除术并植入后房型阿列克谢耶夫人工晶状体（IOL）。手术并发症患者及患眼有炎症病史者未纳入研究。为评估淋巴疗法对血液中药物浓度的影响，对患眼球结膜小静脉中的血流聚集梯度进行了评估。数据表明，淋巴疗法是治疗人工晶状体植入术后早期炎症的有效方法，与传统疗法相比缩短了治疗时间。
